6.43

3.46% 0.215

After Hours: 6.43

Meiragtx Holdings Plc (MGTX)

Overview News Price History Option Chain Financials Discussions Forecast

Meiragtx Holdings Plc stock is traded at $6.43, with a volume of 216.84K. It is up +3.46% in the last 24 hours and up +9.17% over the past month. MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Previous Close:

$6.215

Open:

$6.28

24h Volume:

216.84K

Relative Volume:

0.74

Market Cap:

$502.53M

Revenue:

$14.02M

Net Income/Loss:

$-84.03M

P/E Ratio:

-4.3741

EPS:

-1.47

Net Cash Flow:

$-125.54M

1W Performance:

+5.93%

1M Performance:

+9.17%

6M Performance:

+30.69%

1Y Performance:

+1.90%

1-Day Range:

$6.28

$6.595

1-Week Range:

$5.94

$6.595

52-Week Range:

$3.85

$7.37

Meiragtx Holdings Plc Stock (MGTX) Company Profile

Name

Meiragtx Holdings Plc

Sector

Healthcare (1174)

Industry

Biotechnology (678)

Phone

646-860-7985

Address

450 EAST 29TH STREET, NEW YORK, NY

Employee

389

Twitter

@MeiraGTx

Next Earnings Date

2024-11-12

Latest SEC Filings

MGTX's Discussions on Twitter

Compare MGTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MGTX Meiragtx Holdings Plc	6.43	502.53M	14.02M	-84.03M	-125.54M	-1.47
VRTX Vertex Pharmaceuticals Inc	438.40	112.90B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	683.08	75.06B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	665.68	40.45B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	277.16	35.75B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	120.88	28.98B	3.30B	-501.07M	1.03B	-2.1146

Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-31-24	Resumed	Chardan Capital Markets	Buy
Oct-23-20	Initiated	RBC Capital Mkts	Outperform
Sep-15-20	Resumed	BofA Securities	Buy
Sep-03-19	Initiated	Piper Jaffray	Overweight
Feb-27-19	Reiterated	Chardan Capital Markets	Buy
Jul-03-18	Initiated	Barclays	Overweight
Jul-03-18	Initiated	BofA/Merrill	Buy

View All

Meiragtx Holdings Plc Stock (MGTX) Latest News

Jan 29, 2025

MeiraGTx Holdings plc's (NASDAQ:MGTX) top owners are private equity firms with 25% stake, while 21% is held by institutions - Yahoo Finance

Jan 29, 2025

Jan 24, 2025

MeiraGTx receives rare pediatric disease designation from FDA for its eye disease treatment - MSN

Jan 24, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by JPMorgan Chase & Co. - Defense World

Jan 24, 2025

Jan 23, 2025

MeiraGTx wins RPD designation for Leber candidate - The Pharma Letter

Jan 23, 2025

MeiraGTX CFO Richard Giroux sells $150,960 in ordinary shares - MSN

Jan 23, 2025

Jan 22, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) CFO Richard Giroux Sells 24,000 Shares - MarketBeat

Jan 22, 2025

MeiraGTx: 2 Possible Near-Term BLA Filings Could Ignite Shareholder Value (NASDAQ:MGTX) - Seeking Alpha

Jan 22, 2025

MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis Due to GUCY2D Mutations - Marketscreener.com

Jan 22, 2025

MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Mutations - The Manila Times

Jan 22, 2025

MeiraGTx Secures Fourth FDA Rare Pediatric Disease Designation for Gene Therapy Treatment - StockTitan

Jan 22, 2025

Jan 21, 2025

MeiraGTX CFO Richard Giroux sells $150,960 in ordinary shares By Investing.com - Investing.com South Africa

Jan 21, 2025

Long Term Trading Analysis for (MGTX) - Stock Traders Daily

Jan 21, 2025

Jan 20, 2025

Is MeiraGTx Holdings plc (MGTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey

Jan 20, 2025

Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks - Insider Monkey

Jan 20, 2025

Jan 18, 2025

MeiraGTx (NASDAQ:MGTX) Trading 8% HigherWhat's Next? - MarketBeat

Jan 18, 2025

Jan 17, 2025

Barclays PLC Acquires 76,437 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Jan 17, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Acquired by Barclays PLC - MarketBeat

Jan 17, 2025

Jan 15, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by Jane Street Group LLC - Defense World

Jan 15, 2025

Jan 14, 2025

Contrasting Innate Pharma (OTCMKTS:IPHYF) and MeiraGTx (NASDAQ:MGTX) - Defense World

Jan 14, 2025

Jan 10, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Sells $231,878.33 in Stock - MarketBeat

Jan 10, 2025

MeiraGTX president sells shares worth $305,342 By Investing.com - Investing.com Nigeria

Jan 10, 2025

Head-To-Head Survey: Tevogen Bio (NASDAQ:TVGN) and MeiraGTx (NASDAQ:MGTX) - Defense World

Jan 10, 2025

Jan 09, 2025

Geode Capital Management LLC Cuts Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Jan 09, 2025

Jan 02, 2025

High Growth Tech Stocks in the United States - Simply Wall St

Jan 02, 2025

MeiraGTx Holdings plc (NASDAQ:MGTX) Stock Holdings Lifted by Barclays PLC - Defense World

Jan 02, 2025

Jan 01, 2025

State Street Corp Boosts Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Jan 01, 2025

Dec 31, 2024

How the (MGTX) price action is used to our Advantage - Stock Traders Daily

Dec 31, 2024

Dec 29, 2024